List view / Grid view

Pharmaceutical Supply Chain Initiative (PSCI)



ESG considerations in Europe and Asia: social inclusion – the new diversity frontier in life sciences

1 July 2022 | By ,

With the focus on environmental, social and governance (ESG) issues rising worldwide, in this article, Morgan, Lewis & Bockius LLP Partners, Lesli Ligorner and Louise Skinner discuss the evolving landscape, presenting the emerging regulations for reporting social factors across Asia and Europe.